Key result
During total hip replacement, marked reductions in arterial blood pressure and oxygen tension correlated significantly with the release of tissue-thromboplastic products into the pulmonary circulation.
Why the study?
Does the release of tissue-thromboplastic products, fat embolism, or acrylic monomers cause arterial hypotension and hypoxaemia during total hip replacement?
Observational (n=13)
Does the release of tissue-thromboplastic products, fat embolism, or acrylic monomers cause arterial hypotension and hypoxaemia during total hip replacement?
Intraoperative hypotension and hypoxaemia during total hip replacement are primarily driven by the release of tissue-thromboplastic products rather than fat embolism or acrylic monomers.
No takes yet. Share an insight, caveat, or question.
May implicate tissue-thromboplastic products over fat or monomers in hip-replacement instability; hypothesis-generating and should not yet change practice.
Modig et al. (1975) conducted an observational in Total hip replacement surgery (n=13). Total hip replacement surgery (impaction of femoral prosthesis) was evaluated on Arterial blood pressure and arterial oxygen tension reductions. During total hip replacement, marked reductions in arterial blood pressure and oxygen tension correlated significantly with the release of tissue-thromboplastic products into the pulmonary circulation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: